0001596783-23-000168.txt : 20231102 0001596783-23-000168.hdr.sgml : 20231102 20231102211701 ACCESSION NUMBER: 0001596783-23-000168 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231025 FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McErlane David CENTRAL INDEX KEY: 0001999358 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 231374275 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 3 1 wk-form3_1698974210.xml FORM 3 X0206 3 2023-10-25 0 0001596783 Catalent, Inc. CTLT 0001999358 McErlane David C/O CATALENT. INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 Group President, Biologics Common Stock 19552 D Options to purchase Common Stock 45.79 2033-09-25 Common Stock 14740 D Restricted stock units, each representing the right to receive one share of Issuer's common stock as of the date of vesting, which is scheduled to occur in three equal annual installments beginning on September 25, 2024. The options vest and become exercisable in four equal annual installments beginning on September 25, 2024. /s/ Amy Fallone, attorney-in-fact 2023-11-02 EX-24.POA 2 poa_mcerlane.txt EX-24.POA POWER OF ATTORNEY Know all by these presents that the undersigned does hereby make, constitute, and appoint each of Amy Fallone and Joseph Ferraro, or either of them, as a true and lawful attorney-in-fact of the undersigned, with full powers of substitution and revocation, for and in the name, place, and stead of the undersigned (in the undersigned's individual capacity) to execute and deliver such forms that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Catalent, Inc. (i) pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended ("Section 16"), including without limitation statements on Form 3, Form 4, and Form 5, and any amendments thereto; and (ii) in connection with any applications for EDGAR access codes, including without limitation the Form ID. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to make filings pursuant to Section 16 with regard to the undersigned's ownership of or transactions in securities of Catalent, Inc., unless earlier revoked in writing. The undersigned acknowledges that Amy Fallone and Joseph Ferraro are not assuming any of the undersigned's responsibilities to comply with Section 16. /s/ David McErlane ---------------------------------- David McErlane Date: October 31, 2023